18 Apr 2024

Press & news

FluoGuide develops surgical solutions that is expected to reduce suffering for the patient and increases the likelihood of cure as well as reducing costs for the health care system.

New - New exchange: Nasdaq First North

FluoGuide is moving from Spotlight to Nasdaq First North. Shareholders are strongly encouraged to make sure they will be able to freely trade their shares in the future.

Financial calendar 2022 for FluoGuide, and release of the Q3 report 2021 is moved to 15[th] of November 2021


November 5, 2021

Copenhagen, Denmark, 5 November 2021 – FluoGuide A/S (“FluoGuide” or the “Company”) releases financial calendar for 2022. The planned release of Q3 financial report 2021 is changed to 15[th] of November 2021

Financial calendar for 2022

Year-end report 2021 and Annual report 2021 30 March 2022
Annual General Meeting 18 May 2022
Q1 2022 report 31 May 2022
Q2 2022 report 25 August 2022
Q3 2022 report 24 November 2022


The planned release of the Q3 financial report 2021 is moved from 24th November to 15th November 2021.